Director Shareholding

GlaxoSmithKline PLC
04 March 2003

                              Directors' Interests

I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.


          The Administrators of the GlaxoSmithKline US Retirement
          Savings Plan ("the Plan") notified GlaxoSmithKline plc on 3
          March 2003, that as a result of movement in the fund on the
          28 February 2003, the number of Ordinary Share ADRs held by
          the fund had increased from 18,461,602 to 18,596,424 at an
          average price of $35.05.




The Plan is a discretionary fund of which all employees or former employees of
GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the
Company's directors, Dr J P Garnier is therefore potentially interested in the
shares held in the fund from time to time in the same way as other employees or
former employees of GlaxoSmithKline plc and its subsidiaries.




S M Bicknell

Company Secretary


4 March 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange